The discovery of small RNA, such as miRNA and siRNA, opened a new dimension in gene regulation on the level of transcriptional and post-transcriptional regulation (1). To understand the distribution and expression levels of small RNAs is therefore crucial to understand tissue development (2), diseases (3), therapies with xenobiotic medicaments (4) or with small RNAs (5). Furthermore, each cell type, each tissue has a different onset of small RNAs and their expression. Only a large amount of samples from all these tissues will reveal the whole "small RNA-om". Technologies such as NGS heavily supports the investigations of these small RNA such as that a deep sequencing approach gives a holistic view of a snapshot of the small RNA regulatory activity in a biological sample. With the increasing number of sequence output offered by the different NGS technologies, the analysis of these large numbers of sequences especially for small RNA data analysis become time consuming and prone of errors in respect of the prediction of new small RNAs.
